Moreover, in cells treated only with butyrate, the expression of pro-apoptotic PTEN and anti-tumor TNFα increased (p ≤ 0.05), whereas anti-apoptotic BCL2 was reduced (p ≤ 0.001) compared to PA1B1 treatment. This evidence concerns the gene BCL2 and neoplasm.